9.20
price down icon0.11%   -0.01
after-market Handel nachbörslich: 9.13 -0.07 -0.76%
loading
Schlusskurs vom Vortag:
$9.21
Offen:
$9.2
24-Stunden-Volumen:
1.12M
Relative Volume:
1.11
Marktkapitalisierung:
$636.37M
Einnahmen:
$202.09M
Nettoeinkommen (Verlust:
$-61.69M
KGV:
-8.5185
EPS:
-1.08
Netto-Cashflow:
$-35.64M
1W Leistung:
-4.37%
1M Leistung:
+0.11%
6M Leistung:
-16.67%
1J Leistung:
-16.97%
1-Tages-Spanne:
Value
$9.00
$9.625
1-Wochen-Bereich:
Value
$9.00
$9.625
52-Wochen-Spanne:
Value
$8.67
$17.82

Evolus Inc Stock (EOLS) Company Profile

Name
Firmenname
Evolus Inc
Name
Telefon
(949) 284-4555
Name
Adresse
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Name
Mitarbeiter
372
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
EOLS's Discussions on Twitter

Vergleichen Sie EOLS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
EOLS
Evolus Inc
9.20 636.37M 202.09M -61.69M -35.64M -1.08
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
14.60 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.19 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.35 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.37 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.64 20.17B 16.54B -1.64B 749.00M -1.45

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-17 Eingeleitet BTIG Research Buy
2024-01-29 Hochstufung Barclays Equal Weight → Overweight
2022-06-23 Eingeleitet Needham Buy
2022-05-12 Hochstufung Barclays Underweight → Equal Weight
2022-01-20 Hochstufung Truist Hold → Buy
2021-05-06 Hochstufung Mizuho Neutral → Buy
2021-04-08 Bestätigt H.C. Wainwright Buy
2021-02-24 Herabstufung Truist Buy → Hold
2020-07-07 Herabstufung Mizuho Buy → Neutral
2020-02-06 Fortgesetzt Mizuho Buy
2019-11-26 Eingeleitet SVB Leerink Outperform
2019-09-05 Fortgesetzt Mizuho Buy
2019-06-28 Eingeleitet Wells Fargo Market Perform
2019-06-11 Eingeleitet Barclays Underweight
2019-03-20 Eingeleitet SunTrust Buy
2019-02-14 Eingeleitet H.C. Wainwright Buy
2019-01-29 Eingeleitet Stifel Buy
Alle ansehen

Evolus Inc Aktie (EOLS) Neueste Nachrichten

pulisher
Jun 16, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 13, 2025 - BioSpace

Jun 16, 2025
pulisher
Jun 14, 2025

(EOLS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 13, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Midday Stock Roundup: Xponential Fitness Down, Yoshiharu Up - Orange County Business Journal

Jun 13, 2025
pulisher
Jun 11, 2025

Evolus Inc (EOLS) Stock Price Up 3.95% on Jun 11 - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Insider Spends US$189k Buying More Shares In Evolus - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Insider Buying: White Albert G III Acquires 20,000 Shares of Evolus Inc (EOLS) - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

EOLS Director Boosts Stake with Significant Share Purchase | EOLS Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Evolysse™ Recognized in 2025 Shape Skin Awards | EOLS Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Evolysse™ Recognized in 2025 Shape Skin Awards - Yahoo Finance

Jun 10, 2025
pulisher
Jun 07, 2025

Evolus, Inc. (NASDAQ:EOLS) Holdings Lowered by Squarepoint Ops LLC - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Evolus Announces Board Changes and Director Elections - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Evolus, Inc. (EOLS) Stock Analysis: A 142% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews

Jun 06, 2025
pulisher
Jun 04, 2025

Evolus, Inc. (NASDAQ:EOLS) Shares Acquired by Bank of America Corp DE - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

EOLS Set to Participate in BTIG's Virtual Meeting on June 9 | EO - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Evolus, Inc. (NASDAQ:EOLS) Shares Bought by Ameriprise Financial Inc. - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

EOLS Set to Participate in BTIG's Virtual Meeting on June 9 | EOLS Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Evolus Launches Second Product Line for Wrinkles - Orange County Business Journal

Jun 02, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Grows Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Evolus boosts balance sheet with lower-cost refinancing and flexibility - MSN

Jun 01, 2025
pulisher
May 31, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $347,000 Stock Position in Evolus, Inc. (NASDAQ:EOLS) - Defense World

May 31, 2025
pulisher
May 30, 2025

Evolus announces CFO resignation - MSN

May 30, 2025
pulisher
May 30, 2025

Stifel maintains Evolus stock buy rating, $25 target - Investing.com Australia

May 30, 2025
pulisher
May 30, 2025

Stifel maintains Evolus stock buy rating, $25 target By Investing.com - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

Increases to CEO Compensation Might Be Put On Hold For Now at Evolus, Inc. (NASDAQ:EOLS) - simplywall.st

May 30, 2025
pulisher
May 28, 2025

Mizuho maintains Evolus stock Outperform rating and $25 target By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Evolus CFO Sandra Beaver resigns for new role By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

Mizuho maintains Evolus stock Outperform rating and $25 target - Investing.com

May 28, 2025
pulisher
May 27, 2025

Evolus CFO to Resign - Orange County Business Journal

May 27, 2025
pulisher
May 27, 2025

Evolus CFO Sandra Beaver Resigns - MarketScreener

May 27, 2025
pulisher
May 27, 2025

Evolus (EOLS) CFO Resignation Announced - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Evolus CFO Sandra Beaver resigns for new role - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Evolus CFO Sandra Beaver Announces Resignation - TipRanks

May 27, 2025
pulisher
May 27, 2025

Resignation of CFO Impacts Evolus (EOLS) Leadership | EOLS Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Evolus Announces Departure of its Chief Financial Officer | EOLS Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Evolus announces departure of CFO Sandra Beaver - TipRanks

May 27, 2025
pulisher
May 27, 2025

Evolus Announces Departure Of Its Chief Financial Officer - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Evolus Announces Departure of its Chief Financial Officer - Business Wire

May 27, 2025
pulisher
May 26, 2025

BNP Paribas Financial Markets Has $400,000 Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - Defense World

May 26, 2025
pulisher
May 22, 2025

Evolysse HA gels outperform Restylane in clinical study - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Evolus announces publication of U.S. pivotal study for Evolysse injectable gels - TipRanks

May 22, 2025
pulisher
May 22, 2025

EOLS Publishes Promising Study Results on Evolysse Injectable Gels | EOLS Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels - BioSpace

May 22, 2025
pulisher
May 22, 2025

Evolysse HA gels outperform Restylane in clinical study By Investing.com - Investing.com Canada

May 22, 2025
pulisher
May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels | EOLS Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Trend Tracker for (EOLS) - news.stocktradersdaily.com

May 22, 2025
pulisher
May 21, 2025

Deutsche Bank AG Cuts Stock Holdings in Evolus, Inc. (NASDAQ:EOLS) - Defense World

May 21, 2025
pulisher
May 17, 2025

Comerica Bank Purchases New Stake in Evolus, Inc. (NASDAQ:EOLS) - Defense World

May 17, 2025

Finanzdaten der Evolus Inc-Aktie (EOLS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Evolus Inc-Aktie (EOLS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MOATAZEDI DAVID
See Remarks
Jun 16 '25
Sale
9.89
16,582
164,054
364,927
$14.43
price up icon 1.05%
$9.18
price up icon 2.80%
$128.00
price up icon 1.84%
$290.91
price up icon 1.24%
drug_manufacturers_specialty_generic RDY
$14.94
price down icon 0.60%
$16.64
price down icon 0.72%
Kapitalisierung:     |  Volumen (24h):